The Wall Street Journal
Doctors and hospitals are getting a new test that many think will help fight ovarian cancer, one of the deadliest cancers, by helping them to more quickly distinguish cancerous from benign growths.
The test, which is called OVA1 and will be available for general use
Tuesday, was shown to correctly flag 92% of cancers, when used along
with radiological imaging and a standard patient work-up, in a study of
27 hospitals, doctors' offices and clinics. Physicians using their
usual detection methods but not OVA1 had previously found 72% of the
cancers... read more